China Pharma Holdings, Inc. (CPHI)
CPHIAMEXBiotechnology: Pharmaceutical Preparations
$0.5215
-0.0350 (-6.29%) today
Closed, Nov 13, 3:56 PM ET
- Market cap
- $22.29m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.3818 to $19.19
- Average volume
- –
- Previous close
- $0.5565
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $756.0k | $1.23m | $984.0k | $948.0k |
| Gross profit | -$60.0k | $151.0k | $285.0k | $84.0k |
| Operating income | -$628.0k | -$1.20m | -$1.12m | -$1.43m |
| Net income | -$651.0k | -$1.22m | -$1.14m | -$1.46m |
Last four quarters: revenue $3.91m, margin -114.3%, free cash flow –
News
3 latestThe company
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- AMEX
- Region
- Asia
- Website
- chinapharmaholdings.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.